Connection

Robert Gemmill to Von Hippel-Lindau Tumor Suppressor Protein

This is a "connection" page, showing publications Robert Gemmill has written about Von Hippel-Lindau Tumor Suppressor Protein.
  1. Synergistic growth inhibition by Iressa and Rapamycin is modulated by VHL mutations in renal cell carcinoma. Br J Cancer. 2005 Jun 20; 92(12):2266-77.
    View in: PubMed
    Score: 0.061
  2. The TRC8 hereditary kidney cancer gene suppresses growth and functions with VHL in a common pathway. Oncogene. 2002 May 16; 21(22):3507-16.
    View in: PubMed
    Score: 0.049
  3. Gene expression profiling identifies inflammation and angiogenesis as distinguishing features of canine hemangiosarcoma. BMC Cancer. 2010 Nov 09; 10:619.
    View in: PubMed
    Score: 0.022
  4. The tumor suppressor gene TRC8/RNF139 is disrupted by a constitutional balanced translocation t(8;22)(q24.13;q11.21) in a young girl with dysgerminoma. Mol Cancer. 2009 Jul 30; 8:52.
    View in: PubMed
    Score: 0.020
  5. A constitutional balanced t(3;8)(p14;q24.1) translocation results in disruption of the TRC8 gene and predisposition to clear cell renal cell carcinoma. Genes Chromosomes Cancer. 2007 Sep; 46(9):805-12.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.